Advanced search
Publication Cover
Current Medical Research and Opinion Volume 21, 2005 - Issue 9
Submit an article Journal homepage
181
Views
65
CrossRef citations to date
0
Altmetric
Original Article

Lipid-modifying therapy and attainment of cholesterol goals in Europe: the Return on Expenditure Achieved for Lipid Therapy (REALITY) study

Eric Van Ganse Pharmacoepidemiology EA 3091 Centre Hospitalier Lyon-Sud, FranceCorrespondenceeric.van‐ganse@chu
,
Laurent Laforest Pharmacoepidemiology EA 3091 Centre Hospitalier Lyon-Sud, France
,
Evo Alemao Outcomes Research, Merck and Co. Inc., Whitehouse Station, NJ, USA
,
Glenn Davies Health Economic Statistics, Merck Research Laboratories, Blue Bell, PA, USA
,
Stephen Gutkin Rete Biomedical Communications Corp., Ridgewood, NJ, USA
&
Don Yin Outcomes Research, Merck and Co. Inc., Whitehouse Station, NJ, USA
Pages 1389-1399 | Accepted 14 Jul 2005, Published online: 10 Aug 2005

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.